Global Specialty Pharmaceuticals Market Forecast Report 2023: Unveiling the Phenomenal Growth - Specialty Pharmaceuticals Market to Reach $965.54 Billion by 2030
September 12, 2023 06:43 ET
|
Research and Markets
Dublin, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The "Global Specialty Pharmaceuticals Market by Type, Product, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High...
Global Specialty Drug Distribution Market 2023-2028: AmerisourceBergen, Pfizer, McKesson, CVS Health and Sinopharm Drive Innovations
August 31, 2023 06:28 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Specialty Drug Distribution Market (2023-2028) by Indications, Type, End User, and Geography, Competitive Analysis, Impact of Covid-19 and...
Emerging Trends in Acute Lymphoblastic Leukemia Treatment Market - New Report Reveals Forecast 2023-2030
August 16, 2023 06:03 ET
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market by Types of Cell, Therapy, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
August 10, 2023 16:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next...
AI In Pharma Global Market Report 2023-2027: Shortage of Skilled Professionals Poses Challenge to AI in Pharma Market Growth
August 04, 2023 06:43 ET
|
Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "AI In Pharma Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global AI in pharma market experienced...
Global Anti-Hypertensive Drugs Market Analysis and Outlook 2023-2027: FDA Emphasizes Rise of Combination Therapies for Hypertension Treatment
July 28, 2023 05:38 ET
|
Research and Markets
Dublin, July 28, 2023 (GLOBE NEWSWIRE) -- The "Anti-Hypertensive Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global anti-hypertensive drugs...
Nanopharmaceuticals Industry Analysis 2023-2030: Lack of Regulatory Guidelines and Concerns About Toxicity Issues Pose Challenges
July 27, 2023 07:08 ET
|
Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Global Nanopharmaceuticals Market Outlook 2023-2030" report has been added to ResearchAndMarkets.com's offering. The Global Nanopharmaceuticals...
Global Drugs for Erectile Dysfunction Market 2023-2027: Insights & Projections for Sildenafil, Mirodenafil, and Vardenafil
July 27, 2023 05:18 ET
|
Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Drugs For Erectile Dysfunction Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global drugs for erectile...
LIXTE Biotechnology Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
July 18, 2023 08:00 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, July 18, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced it has entered into a securities purchase...
LIXTE Biotechnology Holdings, Inc. Regains Compliance with Nasdaq Continued Listing Requirements
June 23, 2023 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, June 23, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“LIXTE” or the “Company”) announced today that it has received confirmation from The Nasdaq Stock...